Light AI Wellness Application Q3 2025 Launch
VANCOUVER, BC, July 7, 2025 /CNW/ - Light AI Inc. (" Light AI" or the " Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on developing artificial intelligence ("AI") health diagnostic and wellness solutions is pleased to announce that it has achieved key internal milestones in the development of its Wellness Strep A screening application.
"We have made significant progress in the development of the Company's commercial platform since the beginning of 2025. These include the introduction of a multiplatform version of our mobile application with both Android and IOS smartphone and tablet support as well as robust scalability and security for our hyper-scale-based backend AI systems," stated Anthony Schaller, President and CTO of Light AI. "This significant product development investment positions the Company well as it transitions to its commercialization phase."
The Company's AI powered software platform is currently undergoing internal user testing by Light AI and its low and middle income countries go-to-market partner, Tech Care For All.
The Company continues to progress with its initial commercialization efforts for its Wellness Application, inclusive of potential targeted market-demonstration deployments with pharmacy companies. Commercial availability of the Company's Wellness Application remains targeted for late 2025.
The global AI healthcare market is projected to reach US$110.6 billion by 2030 from US$21.7 billion in 2025, at a CAGR of approximately 39% based upon adoption to new AI health and wellness solutions. The market is anticipated to grow due to the growing investments & funding by public-private organizations, the fast proliferation of AI in the healthcare industry, and the rising focus on developing human-aware AI systems. The market is experiencing growth due to increasing demand for enhanced services due to an unequal ratio between the healthcare workforce and patient numbers. However, inadequate IT infrastructure and unwillingness to adopt AI-based healthcare solutions in emerging economies are estimated to pose a challenge to market growth to be addressed. 1
"We are receiving positive feedback to Light AI's Wellness Application anticipated to support our initial commercialization initiatives," stated John Tse, Vice President of Commercial Development. "We look forward to making a positive impact in the health and wellness market's digital health paradigm shift evolution."
About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)
Light AI Inc. is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions —to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative screening and diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective screening and diagnostic tools designed to address critical healthcare challenges.
In pre-FDA validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI's technology offers a significant advancement in the accurate and timely identification of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI's vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes. Light AI's commercial launch of its consumer-facing Wellness App initial offering is anticipated to be available in North America in Q3 2025.
ON BEHALF OF THE COMPANY
For more information, please contact the Company at [email protected] or visit https://light.ai/.
Forward-Looking Information:
This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the Company's research and development and commercialization initiatives, the anticipated inflection of the business, the Company's financial and operational performance and outlook and other statements that contain words such as "believe," "expect," "project," "should," "seek," "anticipate," "will," "intend," "positioned," "risk," "plan," "may," "estimate" or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release. For a list of the factors that may affect any of the Company's forward-looking statements, please refer to the Company's annual information form dated April 14, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at www.sedarplus.ca
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
3 minutes ago
- CTV News
Canadian dollar to weaken against global markets, currency expert predicts
Sorry, we're having trouble with this video. Please try again later. [5006/404] A foreign exchange expert made a bearish call for the Canadian dollar on Monday, anticipating the loonie will hover around 70 cents against the U.S. dollar as other currencies strengthen. Dan Tobon, head of G10 FX Strategy at Citi Research says he doesn't expect a major collapse in the Canadian dollar, but says a correlation with the U.S. economy, potential for deeper Bank of Canada rate cuts and a removal of positive hedge ratio adjustments will impact it. 'We're not structurally bearish in the dollar, but certainly the next few months could still see some weaker dollars,' Tobon told BNN Bloomberg in an interview. 'It's going to be hard for the Canadian dollar independently to sell off. More likely what will happen is it'll be both the U.S. dollar and the Canadian dollar underperforming everything else.' On Monday afternoon, the Canadian dollar was trading at around 72 cents per one American dollar. Tobon said a soft patch in U.S. labour market data can weigh on the Canadian dollar due to a close relationship between both economies. He noted that Canadian investors have been buying back Canadian dollars as they hedge their U.S. asset exposure, which has supported the currency and said this flow appears to be running out, removing a key source of support for the loonie. 'If you're Canadian and you buy a U.S. asset, you have to sell your Canadian dollars to buy U.S. dollars to buy that asset,' said Tobon. 'Historically, most investors are actually happy to maintain that, because historically, when equity markets go down, the dollar tends to perform well. It's almost like a built-in hedge.' 'The other thing too is U.S. rates tend to be higher, so you're actually earning some carry. This used to be a great scenario. I can buy U.S. equities, I have the dollar exposure where I'm actually earning a little carry, and it's a hedge. In case of risk off. Things have changed a lot this year, and as we saw back in April, we saw the correlation flip, where we saw risk off, but with that risk off, a weaker dollar and higher U.S. Treasury yields. What started happening is this belief that maybe the dollar isn't the hedge that it always was.' He said markets are currently pricing only one more cut from the Bank of Canada over the next year but sees scope for more aggressive cuts than expected. Despite sticky inflation, weakness in other parts of the Canadian economy could lead to deeper rate cuts as inflation normalizes amid the Canada-U.S. trade war. 'We saw a huge amount of Canadian dollar buying by a lot of the Canadian pensions in the first half of the year, especially after April,' said Tobon. 'They weren't necessarily de-risking their U.S. exposure, they were just de-risking their dollar exposure, but that effectively meant they were buying a lot of Canadian dollars over the last couple months.' Loonie against global currencies While some weaknesses against the U.S. dollar is expected, Tobon sees broader Canadian dollar weakness against the European Union's euro, Japanese yen, and other currencies as a bigger concern. One Canadian dollar is trading at around 0.62 Euros and 107 Japanese Yen. 'It's very hard to get a situation where the Canadian dollar is weakening significantly, but maybe the Euro and Australian dollar and these other currencies are strengthening significantly,' said Tobon. 'The betas effectively make the adjustment. Maybe we can get down towards US$70. That's not a monster move from here, but it's something that's definitely notable. The bigger issue is, then, are we going to get broader Canadian weakness against the euro, against the yen, against these other currencies?'
Toronto Star
an hour ago
- Toronto Star
SOVRA Sharpens Focus on GovTech Sector with Series of Strategic Updates
MONTREAL, Aug. 18, 2025 (GLOBE NEWSWIRE) — SOVRA (formerly mdf commerce) ('SOVRA' or 'the Company'), North America's leading public sector procurement platform, announced today a series of strategic updates designed to support the Company in becoming a leading GovTech platform in North America. These include the appointment of a new CEO, the acquisition of Canadian-based government intelligence platform Ontopical, and the divestiture of six non-core business units to Valsoft Corporation ('Valsoft') and another Canadian-based strategic software group specializing in vertical SaaS acquisitions.
Toronto Star
2 hours ago
- Toronto Star
Bocana Resources Corp. Schedules Due Diligence and Site Visit to Arizona Mining Claims
CALGARY, Alberta, Aug. 18, 2025 (GLOBE NEWSWIRE) — Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) ('Bocana' or the 'Company'), further to the press release dated August 11, 2025, in connection with the due diligence efforts of the Company, a site visit to the U.S. Bureau of Land Management ('BLM') placer mining claims (the 'Claims') owned by LP Associates, LLC. in Arizona has been scheduled. As a necessary step that requires proper planning and coordination, the Company management and geologist will be meeting with several parties integral to the successful completion of our current due diligence effort. Key among those visits will be with the seller, the lead on-site geologist, multiple mining consulting firms, legal, and BLM officials. The Company's objective, together with its strategic investors, will be to engage with local consulting firms to verify previously acquired assayed reports within the Claims area and gain a comprehensive understanding of the permitting process for optimal operational development of the Claims. The Company will also take additional ore samples for lab analysis and test various processing methods and strategize with local engineering firms as to the best options for processing this material for the maximum recovery of the various precious metals.
